X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (85) 85
female (79) 79
breast cancer (77) 77
oncology (62) 62
middle aged (54) 54
breast neoplasms - drug therapy (46) 46
adult (44) 44
breast neoplasms - pathology (44) 44
index medicus (44) 44
aged (40) 40
medicine & public health (38) 38
surgical oncology (32) 32
chemotherapy (28) 28
cancer (26) 26
care and treatment (22) 22
treatment outcome (22) 22
surgery (21) 21
breast neoplasms - surgery (19) 19
antineoplastic combined chemotherapy protocols - therapeutic use (18) 18
cancer research (18) 18
prognosis (17) 17
breast neoplasms - mortality (16) 16
cancer patients (15) 15
metastasis (15) 15
survival (15) 15
breast neoplasms - chemistry (14) 14
neoadjuvant therapy (14) 14
neoplasm staging (14) 14
docetaxel (13) 13
quality of life (13) 13
diagnostic radiology (12) 12
imaging / radiology (12) 12
interventional radiology (12) 12
analysis (11) 11
breast neoplasms - metabolism (11) 11
obstetrics & gynecology (11) 11
receptor, erbb-2 - metabolism (11) 11
research (11) 11
young adult (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
therapy (10) 10
women (10) 10
health aspects (9) 9
neoadjuvant chemotherapy (9) 9
prospective studies (9) 9
receptor, erbb-2 - analysis (9) 9
adjuvant treatment (8) 8
aged, 80 and over (8) 8
breast neoplasms - therapy (8) 8
chemotherapy, adjuvant (8) 8
drug administration schedule (8) 8
epidermal growth factor (8) 8
estrogen (8) 8
lymphatic metastasis (8) 8
medical research (8) 8
oncology, experimental (8) 8
patient outcomes (8) 8
surveys and questionnaires (8) 8
taxoids - administration & dosage (8) 8
clinical trials (7) 7
cyclophosphamide - administration & dosage (7) 7
disease-free survival (7) 7
fluorouracil - administration & dosage (7) 7
health care industry (7) 7
medical colleges (7) 7
metastases (7) 7
metastatic breast cancer (7) 7
paclitaxel (7) 7
postmenopausal women (7) 7
postmenopause (7) 7
receptors, estrogen - metabolism (7) 7
survival analysis (7) 7
trastuzumab (7) 7
trial (7) 7
antimitotic agents (6) 6
antineoplastic agents (6) 6
cancer therapies (6) 6
carcinoma (6) 6
cyclophosphamide (6) 6
epidemiology (6) 6
epirubicin - administration & dosage (6) 6
japan (6) 6
medicine, experimental (6) 6
neoplasm metastasis (6) 6
paclitaxel - administration & dosage (6) 6
paclitaxel - adverse effects (6) 6
receptors, estrogen - analysis (6) 6
risk factors (6) 6
sentinel lymph node biopsy (6) 6
social service (6) 6
tamoxifen (6) 6
toxicity (6) 6
antineoplastic agents - therapeutic use (5) 5
biomarkers, tumor - analysis (5) 5
breast neoplasms (5) 5
breast neoplasms - genetics (5) 5
chemistry (5) 5
combined modality therapy (5) 5
cross infection (5) 5
drug therapy (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 22, pp. 2147 - 2159
Journal Article
Nihon rinsho. Japanese journal of clinical medicine, ISSN 0047-1852, 09/2012, Volume 70 Suppl 7, p. 606
Journal Article
by Martin, Miguel and Holmes, Frankie A and Ejlertsen, Bent and Delaloge, Suzette and Moy, Beverly and Iwata, Hiroji and von Minckwitz, Gunter and Chia, Stephen K L and Mansi, Janine and Barrios, Carlos H and Gnant, Michael and Tomašević, Zorica and Denduluri, Neelima and Šeparović, Robert and Gokmen, Erhan and Bashford, Anna and Ruiz Borrego, Manuel and Kim, Sung-Bae and Kim, Seung Jin and Jakobsen, Erik Hugger and Ciceniene, Audrone and Inoue, Kenichi and Overkamp, Friedrich and Heijns, Joan B and Armstrong, Anne C and Link, John S and Joy, Anil Abraham and Bryce, Richard and Wong, Alvin and Moran, Susan and Yao, Bin and Xu, Feng and Xu, Binghe and Auerbach, Alan and Buyse, Marc and Chan, Arlene and Harvey, Vernon and Tomek, Rudolf and Robert, Nicholas J and Gore, Ira and Smith, John W and Smith, Julie C and Masuda, Norikazu and Di Sean Kendall, S and Harker, William Graydon and Petrakova, Katarina and Guerrero Zotano, Angel and Simon, Amparo Ruiz and Konstantinovic, Zora Neskovic and Iannotti, Nicholas O and Tassone, Pierfrancesco and Rodriguez, Gladys I and Jáñez Martinez, Noelia and Crespo Massieu, Carmen and Smickoska, Snezana and Somali, Isil and Yilmaz, Ugur and Alonso, Mirta Garcia and Rosales, Adolfo Murias and Cold, Soeren and Knoop, Ann Soegaard and Patt, Debra and Hellerstedt, Beth A and Morales Murillo, Serafin and Mayer, Ingrid A and Means-Powell, Julie Ann and Hui, Rina and Senecal, Francis M and De Boer, Richard Hendry and Shen, Zhenzhou and Luczak, Adam Andrzej and Chui, Joanna W.Y and Chui, Stephen and Tsang, Janice Wing-hang and Lang, Istvan and Rai, Yoshiaki and Hozumi, Yasuo and Ten Tije, Albert J and Bhandari, Manish and Osborne, Cynthia R.C and Ohtani, Shoichiro and Higaki, Kenji and Watanabe, Junichiro and Watanabe, Kenichi and Taguchi, Tetsuya and Taguchi, Kazunori and Takahashi, Masato and Filipovic, Sladjana and Hansen, Vincent L and Rao, Vijayarama Phooshkooru and Gupta, Manish and Petrov, Petar and Coudert, Bruno and Vojnovic, Zeljko and Polya, Zsofia and Miyaki, Toshiko and Yamamoto, Naohito and Brincat, Stephen and Lesniewski-Kmak, Krzysztof and Chmielowska, Ewa and ... and ExteNET Study Grp and ExteNET Study Group
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1688 - 1700
Journal Article
Nihon rinsho. Japanese journal of clinical medicine, ISSN 0047-1852, 2012, Volume 70, pp. 606 - 613
Journal Article
Journal Article
Cancer Science, ISSN 1347-9032, 06/2015, Volume 106, Issue 6, pp. 734 - 739
We conducted a phase I study of a weekly nab ‐paclitaxel and S‐1 combination therapy in patients with human epidermal growth factor receptor type 2‐negative... 
paclitaxel | S‐1 | phase I study | Combination chemotherapy | nab | metastatic breast cancer | nab-paclitaxel | Phase I study | Metastatic breast cancer | S-1 | SURVIVAL | GUIDELINES | COMBINATION | DOCETAXEL | CHEMOTHERAPY | THERAPY | ONCOLOGY | RECURRENT | ALBUMIN-BOUND PACLITAXEL | ABI-007 | III TRIAL | Drug Administration Schedule | Humans | Middle Aged | Tegafur - adverse effects | Paclitaxel - adverse effects | Albumins - administration & dosage | Paclitaxel - pharmacokinetics | Oxonic Acid - administration & dosage | Breast Neoplasms - drug therapy | Tegafur - pharmacokinetics | Oxonic Acid - adverse effects | Breast Neoplasms - chemistry | Albumins - pharmacokinetics | Albumins - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tegafur - administration & dosage | Adult | Breast Neoplasms - mortality | Female | Aged | Oxonic Acid - pharmacokinetics | Receptor, ErbB-2 - analysis | Paclitaxel - administration & dosage | Drug Combinations | Antimitotic agents | Complications and side effects | Medical research | Care and treatment | Chemotherapy | Epidermal growth factor | Medicine, Experimental | Breast cancer | Metastasis | Antineoplastic agents | Cancer | Toxicity | Cytotoxicity | Peripheral neuropathy | Patients | Cancer therapies | Metastases | Medical prognosis | Paclitaxel | Clinical medicine | Drug dosages | Neutropenia | Pharmaceuticals | Original
Journal Article
Journal Article
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 12/2012, Volume 20, Issue 12, pp. 3355 - 3364
Journal Article
BMC Cancer, ISSN 1471-2407, 2016, Volume 16, Issue 1, p. 230
Journal Article
by Colleoni, Marco and Luo, Weixiu and Karlsson, Per and Chirgwin, Jacquie and Aebi, Stefan and Jerusalem, Guy and Neven, Patrick and Hitre, Erika and Graas, Marie-Pascale and Simoncini, Edda and Kamby, Claus and Thompson, Alastair and Loibl, Sibylle and Gavilá, Joaquín and Kuroi, Katsumasa and Marth, Christian and Müller, Bettina and O'Reilly, Seamus and Di Lauro, Vincenzo and Gombos, Andrea and Ruhstaller, Thomas and Burstein, Harold and Ribi, Karin and Bernhard, Jürg and Viale, Giuseppe and Maibach, Rudolf and Rabaglio-Poretti, Manuela and Gelber, Richard D and Coates, Alan S and Di Leo, Angelo and Regan, Meredith M and Goldhirsch, Aron and Vandebroek, An and Berliere, Martine and Mitine, Carine and Vuylsteke, Peter and Borms, Marleen and D'Hondt, Randal and Glorieux, Philippe and Mebis, Jeroen and Verhoeven, Didier and Coibion, Michael and Forget, Frederic and Duck, Lionel and Wyendaele, Wim and Barbeaux, Annelore and Salmon, Jean-Paul and Berteloot, Patrick and Vermeij, Joanna and Richard, Vincent and Cinieri, Saverio and Gianni, Lorenzo and Clerico, Mario and Pinotti, Graziella and Bernardo, Antonio and Biganzoli, Leo and Gennari, Alessandra and Graiff, Claudio and Amadori, Dino and Passalacqua, Rodolfo and Forbes, John and Francis, Prudence and Foo, Serene and Boyle, Frances and Redfern, Andrew and van der Westhuizen, Andre and Lewis, Craig and Sharma, Ravi and Sharma, Sharad and Beale, Philip and Byard, Ian and Begbie, Stephen and Sardelic, Frank and Abdi, Ehtesham and Clark, David and Chindewere, Aaron and Della-Fiorentina, Stephen and Asghari, Ray and Islam, Mohammed and Na Teo, Lee and White, Shane and Gilbert, Linda and Gardner, Katherine and Uhlmann, Catarina and Rauch, Daniel and Mannhart, Meinrad and Buser, Katharina and Dedes, Konstantin and Mueller, Andreas and Rageth, Christoph and Von Orelli, Stephanie and Senn, Hans Joerg and Pagani, Olivia and Pedrazzini, Augusto and Rochlitz, Christoph and Bodmer, Alexandre and Anchisi, Sandro and Zaman, Khalil and von Moos, Roger and Betticher, Daniel and ... and SOLE Investigators and Institute of Clinical Sciences, Department of Oncology and Sahlgrenska akademin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy and Institutionen för kliniska vetenskaper, Avdelningen för onkologi
The Lancet Oncology, ISSN 1470-2045, 01/2018, Volume 19, Issue 1, pp. 127 - 138
Journal Article